Cosmetic Facial Fillers Increasingly Being Used to Treat Chronic Disease: Infiniti Research

Infiniti Research offers a variety of healthcare market intelligence solutions. (Graphic: Business Wire)

???pagination.previous??? ???pagination.next???

LONDON--()--The number of procedures involving facial injectables is on the rise globally, especially in the US. However, an increasing number of these procedures are being done for health-related reasons rather than beauty-related ones. Though widely thought of as merely a cosmetic treatment, facial injectables and other injectable pharmaceuticals and cosmeceuticals are increasingly being used to treat chronic, non-cosmetic conditions and to improve patients’ overall quality of life. According to Infiniti Research, the global facial injectables market for both cosmetic and non-cosmetic procedures will be valued at more than USD 5 billion by 2020.

Looking for additional pharmaceutical research? Contact our market intelligence experts

When used cosmetically, facial injectables are injected into wrinkles, frown lines, depressions, and other areas of the face that the patient deems to be lacking in volume. The injectable smooths out these perceived problem areas, reducing lines and wrinkles. Depending on the type of filler used and the area treated, injectables can last anywhere from three months to three years. The market for these injectables has been thriving in recent years, according to Infiniti Research, due to growing awareness of anti-aging treatments and the increased affordability of non-invasive cosmetic procedures, as well as the increasing non-cosmetic uses that medicine has found for them. Infiniti Research’s analysts list Botox, hyaluronic acid, and collagen amongst the most popular injectables.

Botox, arguably the most well-known facial injectable, has numerous health-related applications in addition to cosmetic ones. Botox is increasingly being used to treat Parkinson’s disease, Bell’s palsy, and cerebral palsy as it helps to reduce spasticity and relax muscles. In 2010, Botox was approved by the US FDA for the treatment of chronic migraines, and is also now widely used for treating crossed eyes. In the US, Botox has FDA approval for the treatment of a dozen non-cosmetic conditions in addition to cosmetic ones. According to Infiniti Research, due to its versatility and popularity in both cosmetic and non-cosmetic treatments, Botox dominated the global facial injectables market in 2016, accounting for revenue of USD 1.82 billion.

Hyaluronic acid and collagen are similarly versatile. Both are quickly becoming popular treatments for joint disorders, including osteoarthritis. Hyaluronic acid has recently been approved for use in eye surgeries including corneal transplants and cataract removal. The injectable is injected into the eye during the procedure to compensate for dryness and lost natural fluids. According to the latest findings from Infiniti Research, the hyaluronic acid segment is the fastest-growing.

Because of the growing versatility of these injectables and the new uses that are rapidly being found for them, market intelligence is needed for any company looking to enter the facial injectables or injectable pharmaceuticals markets. Vendors must know the most popular uses for each injectable, which age groups they are most popular with, and in which region of the world they are likely to have the most success. They should also be aware of changing methods of delivery of these injectables and the latest upgrades in medical devices used for treatment—for example, in some regions, doctors are increasingly using cannulas instead of needles for delivery of specific injectables in order to significantly reduce patients’ discomfort, but in others, needles remain the dominant method of delivery.

Infiniti Research provides detailed insights into evolving healthcare practices, treatments, consumer preferences, and government and health regulations for a number of healthcare and medicine-related markets. Backed by research centers in multiple emerging markets, Infiniti Research uses information from around the world to help you devise effective growth strategies to cater to the evolving medical world and changes in the global pharmaceutical industry while also providing solutions on how to capitalize on untapped opportunities.

How can Infiniti Research help you? Request a brochure

About Infiniti Research

Established in 2003, Infiniti Research is a leading market intelligence company providing smart solutions to address your business challenges. Infiniti Research studies markets in more than 100 countries to help analyze competitive activity, see beyond market disruptions, and develop intelligent business strategies. With 13 years of experience and offices across three continents, Infiniti Research has been instrumental in providing a complete range of competitive intelligence, strategy, and research services for over 550 companies across the globe.

Contacts

Infiniti Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.infinitiresearch.com
Contact Us

Contacts

Infiniti Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.infinitiresearch.com
Contact Us